Adverse drug reactions and off-label prescribing for paediatric outpatients: a one-year survey of spontaneous reports in Sweden

被引:55
|
作者
Ufer, M [1 ]
Kimland, E
Bergman, U
机构
[1] Huddinge Univ Hosp, Karolinska Inst, Div Clin Pharmacol, SE-14186 Stockholm, Sweden
[2] Univ Tubingen Hosp, Dept Clin Pharmacol, Tubingen, Germany
[3] Stockholm Cty Council, Pharmacoepidemiol Ctr, LAKSAK, Stockholm, Sweden
[4] Huddinge Univ Hosp, Med Prod Agcy, Reg Adverse Drug React Ctr, Stockholm, Sweden
关键词
off-label; children; drug prescribing; paediatric; outpatient; adverse drug reaction;
D O I
10.1002/pds.858
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Purpose To investigate the extent and characteristics of off-label prescribing for paediatric outpatients among drugs reported to have caused an adverse reaction. Methods A retrospective, cross-sectional, observational analysis of spontaneous adverse drug reaction (ADR) reports in Sweden in the year 2000. We included all reports concerning drugs prescribed for outpatients younger than 16 years. Each ADR was classified with respect to its causality, seriousness and type of reaction. Off-label prescribing was evaluated with respect to age, dose, indication, formulation and route and frequency of administration. Results We identified 112 patient-linked reports corresponding to 158 ADRs of which 31% were serious. Antiasthmatic drugs were most frequently suspected as a cause of almost every third adverse reaction. The average proportion of off-label drug prescribing amounted to 42.4%. It was more frequently associated with serious than non-serious ADRs and mostly due to a non-approved age or dose. The most common clinical manifestations were psychiatric disorders and mucocutaneous inflammatory reactions. Conclusions Off-label prescribing for paediatric outpatients is common among drugs reported to have caused an ADR. It is suggested to further identify unlabelled drugs frequently contributing to, in particular serious ADRs in children for a proper benefit-fisk assessment of off-label drug use. Copyright (C) 2003 John Wiley Sons, Ltd.
引用
收藏
页码:147 / 152
页数:6
相关论文
共 50 条
  • [1] Adverse Drug Reactions and Off-Label Drug Use in Paediatric Patients: A One-Year Survey of the French Pharmacovigilance Database
    Durrieu, G.
    Raoul, V
    Montastruc, J.
    [J]. DRUG SAFETY, 2008, 31 (10) : 909 - 910
  • [2] Adverse Drug Reactions and Off-Label Drug Use in Paediatric Patients: A One-Year Survey of the French Pharmacovigilance Database
    G. Durrieu
    V. Raoul
    J. Montastruc
    [J]. Drug Safety, 2008, 31 : 885 - 885
  • [3] Adverse drug reactions and off-label drug use in paediatric patients: a one-year survey of the French Pharmacovigilance database
    Durrieu, G.
    Raoul, V.
    Montastruc, J. L.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2008, 22 : 54 - 54
  • [4] Adverse drug reactions and off-label drug use in paediatric outpatients
    Horen, B
    Montastruc, JL
    Lapeyre-Mestre, M
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 54 (06) : 665 - 670
  • [6] Spontaneous adverse drug reactions and off-label prescribing in children in the Slovak Republic
    Slazneva, J.
    Kamenska, R.
    Kuzelova, M.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (06) : 1336 - 1337
  • [7] Adverse drug reactions and off-label drug prescription in paediatric outpatients: a survey among general practitioners in south western France
    Bissuel, R.
    Palmaro, A.
    Renaud, N.
    Durrieu, G.
    Escourrou, B.
    Montastruc, J. L.
    Mestre, M. Lapeyre
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2013, 27 : 12 - 12
  • [8] The Impact of Unlicensed and Off-Label Drug Use on Adverse Drug Reactions in Paediatric Patients
    Antje Neubert
    Harald Dormann
    Jutta Weiss
    Tobias Egger
    Manfred Criegee-Rieck
    Wolfgang Rascher
    Kay Brune
    Burkhard Hinz
    [J]. Drug Safety, 2004, 27 : 1059 - 1067
  • [9] The impact of unlicensed and off-label drug use on adverse drug reactions in paediatric patients
    Neubert, A
    Dormann, H
    Weiss, J
    Egger, T
    Criegee-Rieck, M
    Rascher, W
    Brune, K
    Hinz, B
    [J]. DRUG SAFETY, 2004, 27 (13) : 1059 - 1067
  • [10] Off-label Drug Use and Adverse Drug Events Turning up the Heat on Off-label Prescribing
    Good, Chester B.
    Gellad, Walid F.
    [J]. JAMA INTERNAL MEDICINE, 2016, 176 (01) : 63 - 64